Raynaud's Phenomenon Secondary to Systemic Sclerosis

Also known as: Raynaud Phenomenon Secondary to Systemic Sclerosis

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB05227APD7912Terminated1
DB00770Alprostadil2Completed1
DB01088Iloprost2Completed1
DB11362Selexipag2Completed1
DB00083Botulinum toxin type A3Completed1
DB01088Iloprost3Completed1